GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » Inventory-to-Revenue

Zenith Capital (Zenith Capital) Inventory-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zenith Capital's Average Total Inventories for the quarter that ended in . 20 was $0.00 Mil. Zenith Capital's Revenue for the three months ended in . 20 was $0.00 Mil.

Zenith Capital's Inventory-to-Revenue for the quarter that ended in . 20 stayed the same from . 20 (0.00) to . 20 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Zenith Capital Inventory-to-Revenue Historical Data

The historical data trend for Zenith Capital's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital Inventory-to-Revenue Chart

Zenith Capital Annual Data
Trend
Inventory-to-Revenue

Zenith Capital Quarterly Data
Inventory-to-Revenue

Competitive Comparison of Zenith Capital's Inventory-to-Revenue

For the Biotechnology subindustry, Zenith Capital's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenith Capital's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenith Capital's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zenith Capital's Inventory-to-Revenue falls into.



Zenith Capital Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zenith Capital's Inventory-to-Revenue for the fiscal year that ended in . 20 is calculated as

Inventory-to-Revenue (A: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Revenue (A: . 20 )
=( ( + ) / 1 ) /
=0 /
=N/A

Zenith Capital's Inventory-to-Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue (Q: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Revenue (Q: . 20 )
=( ( + ) / 1 ) /
=0 /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital  (OTCPK:ZHCLF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zenith Capital's Days Inventory for the three months ended in . 20 is calculated as:

Days Inventory=Average Total Inventories (Q: . 20 )/Cost of Goods Sold (Q: . 20 )*Days in Period
=0/*365 / 4
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zenith Capital's Inventory Turnover for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenith Capital Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zenith Capital's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenith Capital (Zenith Capital) Business Description

Traded in Other Exchanges
N/A
Address
300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1
Website
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines